DK0754051T3 - Terapeutisk middel mod forstyrrelse af lipidmetabolisme - Google Patents

Terapeutisk middel mod forstyrrelse af lipidmetabolisme

Info

Publication number
DK0754051T3
DK0754051T3 DK95942270T DK95942270T DK0754051T3 DK 0754051 T3 DK0754051 T3 DK 0754051T3 DK 95942270 T DK95942270 T DK 95942270T DK 95942270 T DK95942270 T DK 95942270T DK 0754051 T3 DK0754051 T3 DK 0754051T3
Authority
DK
Denmark
Prior art keywords
disorder
therapeutic agent
lipid metabolism
present
hypolipidemia
Prior art date
Application number
DK95942270T
Other languages
English (en)
Inventor
Nobuaki Fujise
Kanji Higashio
Hiroaki Masunaga
Akira Shiota
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of DK0754051T3 publication Critical patent/DK0754051T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
DK95942270T 1994-12-27 1995-12-27 Terapeutisk middel mod forstyrrelse af lipidmetabolisme DK0754051T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6337884A JPH08176007A (ja) 1994-12-27 1994-12-27 脂質代謝異常治療剤
PCT/JP1995/002707 WO1996020004A1 (en) 1994-12-27 1995-12-27 Therapeutic agent for disorder of lipid metabolism

Publications (1)

Publication Number Publication Date
DK0754051T3 true DK0754051T3 (da) 2003-09-29

Family

ID=18312906

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95942270T DK0754051T3 (da) 1994-12-27 1995-12-27 Terapeutisk middel mod forstyrrelse af lipidmetabolisme

Country Status (16)

Country Link
EP (1) EP0754051B1 (da)
JP (1) JPH08176007A (da)
KR (1) KR100395695B1 (da)
AT (1) ATE247975T1 (da)
AU (1) AU710513B2 (da)
CA (1) CA2184248A1 (da)
DE (1) DE69531608T2 (da)
DK (1) DK0754051T3 (da)
ES (1) ES2201128T3 (da)
FI (1) FI115826B (da)
HU (1) HU220139B (da)
NO (1) NO318099B1 (da)
NZ (1) NZ298141A (da)
TW (1) TW480173B (da)
WO (1) WO1996020004A1 (da)
ZA (1) ZA9510981B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
KR100568664B1 (ko) * 1997-03-14 2006-06-13 다이이치세이야꾸 가부시끼가이샤 악액질 예방 및/또는 치료제
WO1998041230A1 (fr) * 1997-03-14 1998-09-24 Snow Brand Milk Products Co., Ltd. Agent preventif et/ou curatif de la cachexie
DE69836626T2 (de) 1997-04-11 2007-04-05 Takeda Pharmaceutical Co. Ltd. Proteine mit lecithin-cholesterin acetyltransferase-ähnlicher aktivität, deren herstellung und verwendung
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
DE69334281D1 (de) * 1992-07-16 2009-05-28 Daiichi Sankyo Co Ltd TCF-II enthaltende medizinische Zusammensetzung

Also Published As

Publication number Publication date
ZA9510981B (en) 1996-07-17
DE69531608D1 (de) 2003-10-02
EP0754051B1 (en) 2003-08-27
JPH08176007A (ja) 1996-07-09
FI963312A0 (fi) 1996-08-26
NZ298141A (en) 2000-12-22
AU710513B2 (en) 1999-09-23
WO1996020004A1 (en) 1996-07-04
DE69531608T2 (de) 2004-02-19
CA2184248A1 (en) 1996-07-04
HU9602341D0 (en) 1996-10-28
NO318099B1 (no) 2005-01-31
KR970701058A (ko) 1997-03-17
FI963312A (fi) 1996-08-26
NO963551D0 (no) 1996-08-26
AU4355096A (en) 1996-07-19
KR100395695B1 (ko) 2004-02-14
HU220139B (hu) 2001-11-28
FI115826B (fi) 2005-07-29
TW480173B (en) 2002-03-21
ES2201128T3 (es) 2004-03-16
NO963551L (no) 1996-10-25
HUT76085A (en) 1997-06-30
EP0754051A1 (en) 1997-01-22
ATE247975T1 (de) 2003-09-15

Similar Documents

Publication Publication Date Title
DK0975367T3 (da) Forbedret afgivelse af lægemidler til slimhindeoverflader
AR015487A1 (es) Uso de un compuesto de colesterol hidroxilado como agente reductor para preparar una composicion farmaceutica de utilidad en un metodo para inhibirla oxidacion de las lipoproteinas en un mamifero.
NO962841D0 (no) Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler
DE69434121D1 (de) Pharmazeutische zusammensetzung zur immunstimulierenden therapie
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
ATE228361T1 (de) Reduzierung der kardiotoxizität von antitumormitteln mit manganverbindungen
PT1260582E (pt) Conjugados de factor ix e um polimero biocompativel
BE1002710A5 (fr) Preparation au diclofenac sodique a effet prolonge.
DK1003546T3 (da) Fremgangsmåde til behandling af patienter ramt af dissemineret sklerose ved anvendelse af konsensus interferon
DE69916248D1 (de) D-chiro-inositol-enthaltende zusammensetzungen zur behandlung von metabolischen krankheiten, die durch hyperandrogenismund/oder anovulation gekennzeichnet sind
ATE498427T1 (de) Therapeutische kombinationen
DK0754051T3 (da) Terapeutisk middel mod forstyrrelse af lipidmetabolisme
PT1007055E (pt) Utilizacao de amifostina
DK1035859T3 (da) Anvendelse af phospholipidkomplekser fra ekstrakter af Vitis vinifera som anti-atherosklerotiske midler
DK0977586T3 (da) Kombinationer af antigen og mucosa-bindende bestanddel til induktion af specifik immunologisk tolerans
IL169645A0 (en) Carbohydrate conjugates fto prevent abuse of controlled substances
ES2161750T3 (es) Uso de 17alfa-dihidroequilenina para disminuir el nivel de colesterol.
DE69841573D1 (de) Verfahren zur erhöhung der magnesiumabsorption und verhinderung von artheriosklerose
DK1220676T3 (da) Forebyggelse af colorektal cancer
IT1293067B1 (it) Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico
DK1575531T3 (da) Terapier for kronisk inflammatorisk demyeliniserende polyneuropati under anvendelse af interferon-beta
EA200000531A1 (ru) Применение кетолидов для профилактики тромботических артериальных осложнений, связанных с атеросклерозом
BR0008677A (pt) Composto de tiazolindolinona, composição farmacêutica, e, métodos papa preparar um composto de tiazolindolinona, e de prevenção/reduçao da severidade dos efeitos colaterais de citotoxicidade epitelial da quimioterapia e/ou terapia de radiação
DK0777498T3 (da) Konjugater fremstillet af metalkomplekser og oligonucleotider
CA2290097A1 (fr) Preuves que contraction du mollet ne peut pas augmenter la pression sur la pedale et mecanismes mettant a profit cette decouverte fondamentale